Navigation Links
Treatment for disease that affects estimated 1 in 2000 children gets them to eat again
Date:2/28/2008

INDIANAPOLIS -- Eosinophilic esophagitis, an inflammatory condition known as EE that often mimics reflux and can cause refusal to eat, affects about 1 in 2000 children in the United States and its prevalence is growing. Researchers from the Indiana University School of Medicine and Riley Hospital for Children report that treatment with oral or swallowed/sprayed steroids results in significant patient improvement, but that if discontinued relapse is common.

The results of a randomized clinical trial which compared prednisone and another commonly prescribed medication appears in the February 2008 issue of Clinical Gastroenterology and Hepatology.

EE can be a serious condition and cause children to refuse to eat, to vomit, or to get food stuck as the esophagus narrows from inflammation. EE, which does not improve without treatment, is twice as likely to occur in boys as in girls.

We are seeing increasing numbers of children with EE who can benefit from effective therapy. Our study found that while systemic corticosteroids provided better initial patient improvement compared to swallowed steroids, long term results were similar between the groups, said Sandeep K. Gupta, M.D., IU School of Medicine associate professor of clinical pediatrics and a Riley Hospital pediatric gastroenterologist.

A child will often continue to suffer in silence if this disease is left untreated. We are not sure why the number of cases is increasing, but we are seeing an average of two new cases every week at Riley Hospital. As we study treatment options, we are also investigating how and why food allergies and environmental factors appear to play a role in this disease, said Dr. Gupta.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University
Source:Eurekalert

Page: 1

Related medicine news :

1. FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
2. Biomarkers for Mood May Alter Psychiatric Treatments
3. FDA Issues Not-Approvable Letter for Lillys Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
4. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
5. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
6. Two Drugs Found Equal in Treatment of Septic Shock
7. Exercise and caloric restriction may be treatment method for metabolic syndrome
8. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
9. U of Minnesota study finds thalidomide shows promise for treatment of recurrent ovarian cancer
10. Race, insurance status affect access to transplantation and kidney disease treatment
11. Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... has become a mainstay of multiple myeloma treatment ... system of patients who have received stem cell ... early clinical trial results to be presented by ... American Society of Hematology,s (ASH) annual meeting on ... Convention Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... by researchers from the Medical College of Wisconsin, in ... pain and other sickle cell disease complications in children. ... providers and patients were also identified. The study ... of pediatrics at the Medical College and Children,s Research ... presented at the American Society of Hematology meeting Dec. ...
(Date:12/6/2009)... 2009 A new study provides welcome news for ... thromboembolism (VTE). , The condition is estimated to ... occurs when an abnormal clot forms in a vein ... swelling. In some cases, the clot may detach from ... to the lungs, causing a potentially fatal condition known ...
(Date:12/5/2009)... combination has shown in a phase 1/2 clinical ... the treatment of patients newly diagnosed with multiple myeloma, ... say researchers from Dana-Farber Cancer Institute. , Partial responses ... patients treated with the drug combination in the multi-center ... response rate" in the phase 2 population, reports Paul ...
(Date:12/5/2009)... Blood Cancer Is Most Challenging-- ,, PHILADELPHIA ... identified specific genes, dubbed partner genes, that fuse with ... in infants. By more accurately defining specific partner genes, ... from particular treatments. ,, Oncologists also aim to ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4
... of the threats to themselves and relatives, study says , , ... of families in which some members have BRCA1 or 2 ... ovarian cancer -- typically avoid genetic counseling or testing, a ... testing, they,re less likely than women to pass on the ...
... provide 50 free colonoscopies to patients impacted by the recent economic ... ... -- On Saturday, March 14, the physicians at Digestive Health Specialists ... screening colonoscopies to help those in our communities who have recently ...
... Included in Study Not Atkins DietDENVER, Feb. 27 ... (NEJM) study titled "Comparison of Weight-Loss Diets with ... 26, 2009), concluded that reduced-calorie diets result in ... (fat, protein and carbohydrates) they emphasize. Atkins ...
... surgeons at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis are reporting that artificial discs ... , Click here for more information. , ... , , , ... , , , ...
... FindingsNEWPORT NEWS, Va., Feb. 27 Women facing a ... the same or opposite breast with further testing using ... in the February 2009 "American Journal of Surgery." BSGI ... same or opposite breast in 10.9 percent of newly ...
... New Innovations and Technologies Aimed at Dentists and ConsumersCHICAGO, ... professionals will get a first look at the latest ... Midwinter Meeting. Held February 26 through March 1 at ... more than 570 exhibiting companies from around the world. ...
Other Medicine News:Health News:Men With BRCA Gene Mutations Unaware of Cancer Risks 2Health News:Men With BRCA Gene Mutations Unaware of Cancer Risks 3Health News:Local Gastroenterology Practice Gives Back to the Community During Colon Cancer Awareness Month 2Health News:Atkins Responds to Recent New England Journal of Medicine Weight-Loss Diets Study Results 2Health News:Atkins Responds to Recent New England Journal of Medicine Weight-Loss Diets Study Results 3Health News:Artificial disc replacement as good or better than spinal fusion surgery 2Health News:Artificial disc replacement as good or better than spinal fusion surgery 3Health News:Artificial disc replacement as good or better than spinal fusion surgery 4Health News:Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients 2Health News:Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients 3Health News:One of North America's Largest Exhibitions of Dental Products Brings More than 30,000 Dental Professionals to Chicago 2Health News:One of North America's Largest Exhibitions of Dental Products Brings More than 30,000 Dental Professionals to Chicago 3
(Date:12/4/2009)... inexpensive computer tool that measures volume changes in the ... by a CT scanner can rule out non-cancerous ones ... true cancers with fewer, less expensive and less invasive ... diagnostic guidelines are described in a paper published yesterday ...
(Date:12/4/2009)... Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on ... Reorganization and related amended Disclosure Statement with the United States ... A hearing to consider the adequacy of the Disclosure Statement ... on the confirmation of the Plan scheduled for January 7, ...
(Date:12/4/2009)... 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... and webcast. Principal investigators will discuss the data ... as featured at the 51st American Society of Hematology ... 9:00 a.m. CT/10:00 a.m. ET on Monday, December 7, ...
Breaking Medicine Technology:European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex 28R 29 12913 1China Clean Energy Provides Business Update 12912 1China Clean Energy Provides Business Update 12912 2China Clean Energy Provides Business Update 12912 3US Farms Inc Showcasing Aloe Vera Product Line at Natural MarketPlace 2009 50872 1US Farms Inc Showcasing Aloe Vera Product Line at Natural MarketPlace 2009 50872 2
... able to stimulate insulin,release, TARRYTOWN, N.Y., March ... today results of two clinical,studies conducted in ... Gastroenterology and Hepatology,University Hospital Basel in Basel, ... peptide-1 (7-36 amide) (GLP-1) was to,establish the ...
... Survey Shows 89% of Patients Prefer Orapred ... 2007 /PRNewswire/ -- Alliant,Pharmaceuticals announced today survey ... sodium phosphate,orally disintegrating tablets) over liquid steroids.(1) ... survey involving more than,900 children (n=973), showed ...
Other Medicine Technology:Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 2Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 3Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 4Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 5Orapred ODT Tastes Good 2Orapred ODT Tastes Good 3
... an integral part of the enzymatic cascade ... as well as the degradation of Bradykinin. ... is primarily located in endothelial cells. ACE ... for sarcoidosis and myocardial infarction but is ...
... and quantitative evaluation of pancreatic b-cell function is ... post-diagnostic study of the natural history of diabetes ... as a guide to the correct choice of ... to assess b-cell function because of the ...
... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
... quantitative evaluation of pancreatic -cell function is not ... study of the natural history of diabetes mellitus, ... a guide to the correct choice of treatment. ... -cell function because of the large and variable ...
Medicine Products: